Skip to main content

Advertisement

SpringerLink
Log in

Hypoalbuminemia

  • WARD MEDICINE
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Hypoalbuminemia is frequently observed in hospitalized patients and it can be associated with several different diseases, including cirrhosis, malnutrition, nephrotic syndrome and sepsis. Regardless of its cause, hypoalbuminemia has a strong predictive value on mortality and morbidity. Over the years, the rationale for the use of albumin has been extensively debated and the indications for human serum albumin supplementation have changed. As the knowledge of the pathophysiological mechanisms of the pertinent diseases has increased, the indications for intravenous albumin supplementation have progressively decreased. The purpose of this brief article is to review the causes of hypoalbuminemia and the current indications for intravenous administration of albumin. Based on the available data and considering the costs, albumin supplementation should be limited to well-defined clinical scenarios and to include patients with cirrhosis and spontaneous bacterial peritonitis, patients with cirrhosis undergoing large volume paracentesis, the treatment of type 1 hepatorenal syndrome, fluid resuscitation of patients with sepsis, and therapeutic plasmapheresis with exchange of large volumes of plasma. While albumin supplementation is accepted also in other clinical situations such as burns, nephrotic syndrome, hemorrhagic shock and prevention of hepatorenal syndrome, within these contexts it does not represent a first-choice treatment nor is its use supported by widely accepted guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ballmer PE (2001) Causes and mechanisms of hypoalbuminaemia. Clin Nutr 20:271–273

    Article  PubMed  CAS  Google Scholar 

  2. Hawkins JW, Dugaiczyk A (1982) The human serum albumin gene: structure of a unique locus. Gene 19:55–58

    Article  PubMed  CAS  Google Scholar 

  3. Harper ME, Dugaiczyk A (1983) Linkage of the evolutionary-related serum albumin and alpha-protein genes within q11–22 of human chromosome 4. Am J Hum Genet 35:565–572

    PubMed  CAS  Google Scholar 

  4. Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A (1986) Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11–22 of chromosome 4. J Biol Chem 261:6747–6757

    PubMed  CAS  Google Scholar 

  5. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P (2012) Human serum albumin: from bench to bedside. Mol Aspects Med 33:209–290

    Article  PubMed  CAS  Google Scholar 

  6. Franch-Arcas G (2001) The meaning of hypoalbuminaemia in clinical practice. Clin Nutr 20:265–269

    Article  PubMed  CAS  Google Scholar 

  7. Nicholson JP, Wolmarans MR, Park GR (2000) The role of albumin in critical illness. Br J Anaesth 85:599–610

    Article  PubMed  CAS  Google Scholar 

  8. Rothschild MA, Oratz M, Schreiber SS (1988) Serum albumin. Hepatology 8(2):385–401

    Article  PubMed  CAS  Google Scholar 

  9. Yamauchi A, Fukuhara Y, Yamamoto S, Yano F, Takenaka M, Imai E, Nogichi T, Tanaka T, Kamada T, Ueda N (1992) Oncotic pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat hepatoma cells. Am J Physiol 263:C397–C404

    PubMed  CAS  Google Scholar 

  10. Herrmann FR, Saqfran C, Levkoff SE, Minaker KL (1992) Serum albumin level on admission as a predictor of death, length of stay and readmission. Arch Intern Med 152:125–130

    Article  PubMed  CAS  Google Scholar 

  11. Studer R, Potchen J (1971) The radioisotopic assessment of regional microvascular permeability to macromolecules. Microvasc Res 3:35–48

    Article  PubMed  CAS  Google Scholar 

  12. Boldt J (2010) Use of albumin: an update. Br J Anaesth 104:276–284

    Article  PubMed  CAS  Google Scholar 

  13. Ganong WF (1995) Dynamics of blood and lymph flow. In: Ganong WF (ed) Review of medical physiology, 17th edn. Apple & Lange, EastNorwalk, pp 525–541

    Google Scholar 

  14. Rothuizen J (2009) Important clinical syndromes associated with liver disease. Vet Clin North Am Small Anim Pract 39:419–437

    Article  PubMed  Google Scholar 

  15. Doweiko JP, Nompleggi DJ (1991) Role of albumin in human physiology and pathophysiology. J Parent Enteral Nutr 15:207–211

    Article  CAS  Google Scholar 

  16. Vorobey P, Steindal AE, Off MK, Vorobey A, Moan J (2006) Influence of human serum albumin on photodegradation of folic acid in solution. Photochem Photobiol 82:817–822

    Article  PubMed  CAS  Google Scholar 

  17. Curry S (2009) Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab Pharmacokinet 24:342–357

    Article  PubMed  CAS  Google Scholar 

  18. Bernardi M, Caraceni P, Nivickis RJ, Wilkes MM (2012) Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 55:1172–1181

    Article  PubMed  CAS  Google Scholar 

  19. Wauters J, Wilmer A (2011) Albumin dialysis: current practice and future options. Liver Int 31(Suppl. 3):9–12

    Article  PubMed  Google Scholar 

  20. Nevens F, Laleman W (2012) Artificial liver support devices as treatment option for liver failure. Best Pract Res Clin Gastroenterol 26:17–26

    Article  PubMed  Google Scholar 

  21. Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50:693–703

    Article  PubMed  CAS  Google Scholar 

  22. Gibbs J, Cull W, Henderson W, Doley J, Hur K, Fhuri SF (1999) Preoperative serum albumin level as a predictor of mortality and morbidity. Arch Surg 134:36–42

    Article  PubMed  CAS  Google Scholar 

  23. Moshage HJ, Janssen J, Franssen JH, Hafkenscheid JCM, Yap SH (1987) Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 79:1635–1641

    Article  PubMed  CAS  Google Scholar 

  24. Allison SP, Lobo DN, Stanga Z (2001) The treatment of hypoalbuminaemia. Clin Nutr 20:275–279

    Article  PubMed  CAS  Google Scholar 

  25. Woodcock TE (2012) Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 108:384–394. doi:10.1093/bja/aer515

    Article  PubMed  CAS  Google Scholar 

  26. Ballmer PE, Ochsenbein AF, Schutz-Hofmann S (1994) Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism 43:697–705

    Article  PubMed  CAS  Google Scholar 

  27. Boldt J (2000) The good, the bad, and the ugly: should we completely banish human albumin from our intensive care units? Anesth Analg 91:887–895

    Article  PubMed  CAS  Google Scholar 

  28. Parving HH, Ranek L, Lassen NA (1977) Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver. Scand J Clin Lab Invest 37:643–648

    Article  PubMed  CAS  Google Scholar 

  29. Sitges-Serra A (2001) Introduction to the Symposium on hypoalbuminaemia. Clin Nutr 20:263–264

    Article  Google Scholar 

  30. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM (2003) Hypoalbuminaemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237:319–334

    PubMed  Google Scholar 

  31. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossettias G (2009) Recommendations for the use of albumin and immunoglobulins. Blood Transfus 7:216–234. doi:10.2450/2009.0094-09

    PubMed  Google Scholar 

  32. Anderson P, Bunn F, Li Wan Po A, Li L, Blackhall K, Roberts I, Schierhout G (2011) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 10: CD001208. Update in: Cochrane Database Syst Rev (2011) 11: CD001208

  33. Dellinger RP et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 36:296–327

    Article  PubMed  Google Scholar 

  34. Gines P, Fernandez J, Durand F, Saliba F (2012) Management of critically-ill cirrhotic patients. J Hepatol 56(Suppl 1):S13–S24

    Article  PubMed  CAS  Google Scholar 

  35. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256

    Article  PubMed  CAS  Google Scholar 

  36. Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, Norton R (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333:1044–1046

    Article  PubMed  CAS  Google Scholar 

  37. Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37:86–96

    Article  PubMed  Google Scholar 

  38. SAFE Study Investigator, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, George Institute for International Health, Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357:874–884

    Article  PubMed  CAS  Google Scholar 

  39. Delaney AP, Dan A, McCaffrey J, Finfer S (2011) The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39:386–391

    Article  PubMed  CAS  Google Scholar 

  40. Lasky LC, Finnerty EP, Genis L, Polesky HF (1984) Protein and colloid osmotic pressure changes with albumin and/or saline replacement during plasma exchange. Transfusion 24:256–259

    Article  PubMed  CAS  Google Scholar 

  41. Quillen K, Berkman EM (2003) Introduction to therapeutic apheresis. In: McLeod BC, Price TH, Weinstein R (eds) Apheresis: principles and practice, 2nd edn. AABB Press, Bethesda, pp 49–69

    Google Scholar 

  42. Crookston K, Simon TL (2003) Physiology of apheresis. In: McLeod BC, Price TH, Weinstein R (eds) Apheresis: principles and practice, 2nd edn. AABB Press, Bethesda, pp 71–93

    Google Scholar 

  43. Bunn F, Trivedi D, Ashraf S (2011) Colloid solutions for resuscitation. Cochrane Database Syst Rev 16:CD001319

    Google Scholar 

  44. Boldt J (2010) Safety of nonblood plasma substitutes: less frequently discussed issues. Eur J Anaesthesiol 27:495–500

    PubMed  CAS  Google Scholar 

  45. Vincent JL, Navickis RJ, Wilkes MM (2004) Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 32:2029–2038

    Article  PubMed  CAS  Google Scholar 

  46. Dharmaraj R, Hari P, Bagga A (2009) Randomized cross-over trial comparing albumin and furosemide infusions in nephrotic syndrome. Pediats Nephrol 24:775–782

    Article  Google Scholar 

  47. Elwell RJ, Spencer AP, Eisele G (2003) Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 37:695–700

    Article  PubMed  CAS  Google Scholar 

  48. Gore DC, Dalton JM, Gehr TW (1996) Colloid infusions reduce glomerular filtration in resuscitated burn victims. J Trauma 40:356–360

    Article  PubMed  CAS  Google Scholar 

  49. Angeli P, Gatta A (2005) L’efficacia dell’albumina nell’insufficienza epatica. Minerva Anestesiol 71:17–26

    PubMed  CAS  Google Scholar 

  50. Ginès P (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome. J Hepatol 53:397–417

    Article  Google Scholar 

  51. Ginès P, Cardenas A, Arroyo V, Rodes J (2004) Management of cirrhosis and ascites. N Engl J Med 350:1646–1654

    Article  PubMed  Google Scholar 

  52. Ginès A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Solà R, Ginès P, Terg R, Inglada L, Vaque P, Salerno F, Vargas V, Clemente G, Quer JC, Jimenez W, Arroyo V, Rodes J (1996) Randomized trial comparing albumin, Dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 111:1002–1010

    Article  PubMed  Google Scholar 

  53. Planas R, Gines P, Arroyo V, Llach J, Panes J, Vargas V, Salmeron JM, Gines A, Toledo C, Rimola A, Jimenez W, Asbert M, Gassull MA, Rodes J (1990) Dextran-70 vs. albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 99:1736–1744

    PubMed  CAS  Google Scholar 

  54. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-Del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409

    Article  PubMed  CAS  Google Scholar 

  55. Runyon BA (1999) Albumin infusion for spontaneous bacterial peritonitis. Lancet 354:1838–1839

    Article  PubMed  CAS  Google Scholar 

  56. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Gascia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M, International Ascites Club (2005) Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54:718–7251

    Article  PubMed  CAS  Google Scholar 

  57. Fernandez J, Monteagudo J, Bargallo X, Jimenez W, Bosch J, Arroyo V, Navasa M (2005) Randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 42:627–634

    Article  PubMed  CAS  Google Scholar 

  58. Wong F (2005) Volume expanders for spontaneous bacterial peritonitis: are we comparing oranges with oranges? Hepatology 42:533–535

    Article  PubMed  Google Scholar 

  59. Fernandez J, Gustot T (2012) Management of bacterial infections in cirrhosis. J Hepatol 56(Suppl 1):S1–S12

    Article  PubMed  CAS  Google Scholar 

  60. Arroyo V, Terra C, Ginès P (2006) New treatments of hepatorenal syndrome. Semin Liver Dis 26:254–264

    Article  PubMed  Google Scholar 

  61. Cárdenas A, Ginès P (2006) Therapy insight: management of hepatorenal syndrome. Nat Clin Pract Gastroenterol Hepatol 3:338–348

    Article  PubMed  Google Scholar 

  62. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G (1999) Albumin improves the response to diuretics in patients with cirrhosis and ascites. Results of a randomized, controlled trial. J Hepatol 30:639–645

    Article  PubMed  CAS  Google Scholar 

  63. Gentilini P, Bernardi M, Bolondi L, Craxi A, Gasbarrini G, Ideo G, Laffi G, La Villa G, Salerno F, Ventura E, Pulazzini A, Segantini L, Romanelli RG (2004) The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. Dig Liver Dis 36:539–546

    Article  PubMed  CAS  Google Scholar 

  64. Moreau R, Valla DC, Durand-Zaleski I, Bronowicki JP, Durand F, Chaput JC, Dadamessi I, Silvain C, Bonny C, Oberti F, Gournay J, Lebrec D, Grouin JM, Guemas E, Golly D, Padrazzi B, Tellier Z (2006) Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial. Liver Int 26:46–54

    Article  PubMed  CAS  Google Scholar 

  65. Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS (2010) Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int 30:937–947

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Padova, Padua, Italy

    Angelo Gatta, Alberto Verardo & Massimo Bolognesi

  2. Department of Medicine, Azienda Ospedaliera Università di Padova, Clinica Medica 5, Via Giustiniani 2, 35128, Padua, Italy

    Angelo Gatta

Authors
  1. Angelo Gatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Verardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Bolognesi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelo Gatta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gatta, A., Verardo, A. & Bolognesi, M. Hypoalbuminemia. Intern Emerg Med 7 (Suppl 3), 193–199 (2012). https://doi.org/10.1007/s11739-012-0802-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-012-0802-0

Keywords

Search

Navigation